Katarzyna Grochulska1,2, Brigid Betz-Stablein1,3, Chantal Rutjes1, Frank Po-Chao Chiu1, Scott W Menzies4, H Peter Soyer1,5, Monika Janda6. 1. University of Queensland Diamantina Institute, University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia. 2. Dermatology Department, Medical University of Graz, Graz, Austria. 3. Cancer and Population Studies, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. 4. Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. 5. Dermatology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia. 6. Centre of Health Services Research, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia, m.janda@uq.edu.au.
Abstract
BACKGROUND: Timely diagnosis is the cornerstone of melanoma morbidity and mortality reduction. 2D total body photography and dermoscopy are routinely used to assist with early detection of skin malignancies. Polarized 3D total body photography is a novel technique that enables fast image acquisition of almost the entire skin surface. We aimed to determine the added value of 3D total body photography alongside dermoscopy for monitoring cutaneous lesions. METHODS: Lesion images from high-risk individuals were assessed for long-term substantial changes via dermoscopy and 3D total body photography. Three case studies are presented demonstrating how 3D total body photography may enhance lesion analysis alongside traditional dermoscopy. RESULTS: 3D total body photography can assist clinicians by presenting cutaneous lesions in their skin ecosystem, thereby providing additional clinical context and enabling a more holistic assessment to aid dermoscopy interpretation. For lesion cases where previous dermoscopy is unavailable, corresponding 3D images can substitute for baseline dermoscopy. Additionally, 3D total body photography is not susceptible to artificial stretch artefacts. CONCLUSION: 3D total body photography is valuable alongside dermoscopy for monitoring cutaneous lesions. Furthermore, it is capable of surveilling almost the entire skin surface, including areas not traditionally monitored by sequential imaging.
BACKGROUND: Timely diagnosis is the cornerstone of melanoma morbidity and mortality reduction. 2D total body photography and dermoscopy are routinely used to assist with early detection of skin malignancies. Polarized 3D total body photography is a novel technique that enables fast image acquisition of almost the entire skin surface. We aimed to determine the added value of 3D total body photography alongside dermoscopy for monitoring cutaneous lesions. METHODS: Lesion images from high-risk individuals were assessed for long-term substantial changes via dermoscopy and 3D total body photography. Three case studies are presented demonstrating how 3D total body photography may enhance lesion analysis alongside traditional dermoscopy. RESULTS: 3D total body photography can assist clinicians by presenting cutaneous lesions in their skin ecosystem, thereby providing additional clinical context and enabling a more holistic assessment to aid dermoscopy interpretation. For lesion cases where previous dermoscopy is unavailable, corresponding 3D images can substitute for baseline dermoscopy. Additionally, 3D total body photography is not susceptible to artificial stretch artefacts. CONCLUSION: 3D total body photography is valuable alongside dermoscopy for monitoring cutaneous lesions. Furthermore, it is capable of surveilling almost the entire skin surface, including areas not traditionally monitored by sequential imaging.
Authors: Julie Gachon; Philippe Beaulieu; Jean Francois Sei; Johanny Gouvernet; Jean Paul Claudel; Michel Lemaitre; Marie Aleth Richard; Jean Jacques Grob Journal: Arch Dermatol Date: 2005-04
Authors: Jenna E Rayner; Antonia M Laino; Kaitlin L Nufer; Laura Adams; Anthony P Raphael; Scott W Menzies; H Peter Soyer Journal: Front Med (Lausanne) Date: 2018-05-23
Authors: Clare Amy Primiero; Aideen M McInerney-Leo; Brigid Betz-Stablein; David C Whiteman; Louisa Gordon; Liam Caffery; Joanne F Aitken; Elizabeth Eakin; Sonya Osborne; Len Gray; B Mark Smithers; Monika Janda; H Peter Soyer; Anna Finnane Journal: BMJ Open Date: 2019-11-10 Impact factor: 2.692